ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the glob

Investors need to pay close attention to PODD stock based on the movements in the options market lat

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Insulet (PODD) reached a significant support level, and could be a good pick for investors from a te

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the glob

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo

Deutsche Bank analyst Kieran Ryan initiates coverage on Insulet (NASDAQ:PODD) with a Buy rating a

Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA

Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Insulet Corporation has rebounded with strong revenue and profit growth, now approaching the lower e

STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across ag

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in [url="]tubeless in

U.S. tech stocks plunged more than 3% by midday Friday after a hotter-than-expected jobs report fuel

Insulet (PODD) reported earnings 30 days ago. What's next for the stock?

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-insulin-pump

DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth a

Presentations will feature next generation Omnipod innovations designed to reduce user effort, new a

ACTON, Mass.--(BUSINESS WIRE)--Insulet to Spotlight New Data and Innovations Demonstrating How Omnip

Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in [url="]tubeless in

Enhanced algorithm with new 100 mg/dL Target Glucose and improved alarm handling helps users improve

ACTON, Mass.--(BUSINESS WIRE)--Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and E

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and lowers the pr

Insulet earns a short-term Hold as outlook rises; a $163 sales-based target tests whether growth can

A U.S. ‌appeals court on Thursday overturned a $452 million verdict that ​medical device maker ​Insu

Dow notches fresh all-time high while Nasdaq 100 drops 0.7% as chip stocks unwind. Oil sinks nearly

RBC Capital analyst Shagun Singh reiterates Insulet (NASDAQ:PODD) with a Outperform and maintains

Stock futures rise on Wednesday, with Verra Mobility's shares plunging 45% after Avis Budget Gro

Wall Street analysts changed outlook on top stocks. Check analyst ratings page for all changes, inc

BTIG analyst Marie Thibault maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price targe

Insulet Corporation, Inc. (NASDAQ:PODD) ("Insulet" or the "Company") today announced

B of A Securities analyst Travis Steed maintains Insulet (NASDAQ:PODD) with a Buy and lowers the

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Underweight and lowers the pr

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and lowers

JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Overweight and lowers the

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers

Evercore ISI Group analyst Daniel Markowitz maintains Insulet (NASDAQ:PODD) with a Outperform and

Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and lowe

Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

Oppenheimer analyst Suraj Kalia maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the

BTIG analyst Marie Thibault maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price targe

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.